Hims & Hers Health (CHIX:82WD) Issuance of Debt: €0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:82WD Hims & Hers Health Inc CHIX:82WD
60 GF Score
Price €30.46
GF Value €34.24
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Issuance of Debt?

Hims & Hers Health CHIX:82WD 60 Issuance of Debt is €0 Mil as of Mar. 2026. GuruFocus rates CHIX:82WD with a GF Score™ of 60/100 and a GF Value™ of €34.24 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hims & Hers Health's Issuance of Debt for the three months ended in Mar. 2026 was €0 Mil.

Hims & Hers Health's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Hims & Hers Health Issuance of Debt Related Terms

Hims & Hers Health Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Issuance of Debt Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial 1.19 0.00 0.00 0.00 970.00

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:82WD
60GF Score
Hims & Hers Health Inc CHIX:82WD
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €0 Mil mean?
Hims & Hers Health (CHIX:82WD) has a Issuance of Debt of €0 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Issuance of Debt too high?
Hims & Hers Health's current Issuance of Debt is €0 Mil. Overall, Hims & Hers Health has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Issuance of Debt compare to ?
Hims & Hers Health's Issuance of Debt of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Issuance of Debt is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (CHIX:82WD) is currently considered Modestly Undervalued. The stock's GF Value™ is €34.24, compared to a current price of €30.46 — trading 11% below its estimated fair value. The current Issuance of Debt is €0 Mil. Hims & Hers Health's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Hims & Hers Health (CHIX:82WD), the current Issuance of Debt is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (CHIX:82WD) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of €30.46 is trading 11% below its estimated GF Value™ of €34.24. GuruFocus considers Hims & Hers Health to be Modestly Undervalued.

Key valuation signals for CHIX:82WD:

  • Issuance of Debt: €0 Mil
  • GF Value™: €34.24 vs. price of €30.46 (11% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the CHIX:82WD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
60GF Score

Get the complete analysis for CHIX:82WD

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.46
Price
€34.24
GF Value